The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Localization and function of angiotensin AT1 receptors.
Abstract
The distributions of angiotensin AT1 and AT2 receptors have been mapped by in vitro autoradiography throughout most tissues of many mammals, including humans. In addition to confirming that AT1 receptors occur in sites known to be targets for the physiologic actions of angiotensin, such as the adrenal cortex and medulla, renal glomeruli and proximal tubules, vascular and cardiac muscle and brain circumventricular organs, many new sites of action have been demonstrated. In the kidney, AT1 receptors occur in high density in renal medullary interstitial cells. The function of these cells, which span the interstitial space between the tubules and the vasa rectae, remains to be determined. Renal medullary interstitial cells possess receptors for a number of vasoactive hormones in addition to AT1 receptors and this, in concert with their anatomic location, suggests they may be important for the regulation of fluid reabsorption or renal medullary blood flow. In the heart, the highest densities of AT1 receptors occur in association with the conduction system and vagal ganglia. In the central nervous system, high AT1 receptor densities occur in many regions behind the blood-brain barrier, supporting a role for neurally derived angiotensin as a neuromodulator. The physiologic role of angiotensin in many of these brain sites remains to be determined. The AT2 receptor also has a characteristic distribution in several tissues including the adrenal gland, heart, and brain. The role of this receptor in physiology is being elucidated, but it appears to inhibit proliferation and to participate in development. Thus, receptor-binding studies, localizing the distribution of AT1 and AT2 receptors, provide many insights into novel physiologic roles of angiotensin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The leading role in such actions belongs to the AT1 receptors.”
From Thoroughly Calibrated Modular Agent-Based Model of the Human Cardiovascular and Renal Systems for Blood Pressure Regulation in Health and Disease (2021) · cites this paper as Allen et al., 2000
In the citing paper
“Angiotensin II exerts physiologic actions via binding to receptors on cells of different organs (the kidneys, heart, blood vessels, etc.).”
From Thoroughly Calibrated Modular Agent-Based Model of the Human Cardiovascular and Renal Systems for Blood Pressure Regulation in Health and Disease (2021) · cites this paper as Allen et al., 2000
Citations
Cites
Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,853
Renin-angiotensin system: biochemistry and mechanisms of action.
Peach, M. J. (1977) · Physiological Reviews · doi:10.1152/physrev.1977.57.2.313 · Cited by 1,378
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,252
Stoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 855
Sasaki, K., Yamano, Y., Bardhan, S., Iwai, N., Murray, J. J., Hasegawa, M., Matsudat, Y., & lnagami, T. (1991) · Nature · doi:10.1038/351230a0 · Cited by 811
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., & Kobilka, B. K. (1995) · Nature · doi:10.1038/377744a0 · Cited by 742
Paracrine regulation of the renal microcirculation
Navar, L. G., Inscho, E. W., Majid, S. A., Imig, J. D., Harrison-Bernard, L. M., & Mitchell, K. D. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.425 · Cited by 741
Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui, H., Hamakubo, T., & Inagami, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74499-8 · Cited by 714
Cited by
Items 101–200 of 288
Angiotensin-Converting Enzyme, Renin-Angiotensin System and Human Performance
Woods, D. R. (2009) · Medicine and sport science/Medicine and sport · doi:10.1159/000235697 · Cited by 27
Bkaily, G., Avedanian, L., Al-Khoury, J., Ahmarani, L., Perreault, C., & Jacques, D. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-077 · Cited by 27
Wagner, C. A., Mohebbi, N., Uhlig, U., Giebisch, G., Breton, S., Brown, D., & Geibel, J. P. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335112 · Cited by 27
Wang, Y., Du, S., Hao, Q., Yu, Q., Wu, Z.-T., Deng, Y. L., Chen, Y., Yuan, W., Hu, Q., Su, D., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00518.2013 · Cited by 26
Balthazar, L., Lages, Y., Romano, V. C., Landeira-Fernández, J., & Krahe, T. E. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105354 · Cited by 26
Collister, J. P., Olson, M. K., Nahey, D. B., Vieira, A. A., & Osborn, J. W. (2013) · Physiological Reports · doi:10.1002/phy2.128 · Cited by 26
Carvalho‐Galvão, A., Ogunlade, B., Xu, J., Silva-Alves, C. R. A., Mendes-Júnior, L. G., Guimarães, D. D., Cruz, J. C., de Queiroz, T. M., Balarini, C. M., Braga, V. A., et al. (2018) · Clinical Science · doi:10.1042/cs20180222 · Cited by 26
Angiotensin II and Renal Tubular Ion Transport
Vallés, P. G., Wysocki, J. A., & BATLLE, D. C. (2005) · The Scientific World JOURNAL · doi:10.1100/tsw.2005.92 · Cited by 26
Conner, K., Forbes, M. E., Lee, W. H., Lee, Y. W., & Riddle, D. R. (2011) · Radiation Research · doi:10.1667/rr2560.1 · Cited by 26
Shoemaker, R., Poglitsch, M., Huang, H., Vignes, K., Srinivasan, A., Cockerham, C., Schadler, A. D., Bauer, J. A., & O’Brien, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612728 · Cited by 25
Ibarra-Lara, L., Cervantes-Pérez, L. G., Pérez‐Severiano, F., del Valle‐Mondragón, L., Rubio-Ruiz, M. E., Soria‐Castro, E., Pastelín-Hernández, G. S., Sánchez-Aguilar, M., Martínez‐Lazcano, J. C., & Sánchez-Mendoza, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.039 · Cited by 25
Blood pressure and risk of cancer: a Mendelian randomization study
Chan, I. I., Kwok, M. K., & Schooling, C. M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09067-x · Cited by 24
Involvement of TLR2/4‑MyD88‑NF‑κB signaling pathway in the pathogenesis of intracranial aneurysm
Zhang, X., Wan, Y., Feng, J., Li, M., & Jiang, Z. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11869 · Cited by 23
Maeda, A., Okazaki, T., Inoue, M., Kitazono, T., Yamasaki, M., Lemonnier, F. A., & Ozaki, S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.06.006 · Cited by 22
Kidney Vacuolar H+-ATPase: Physiology and Regulation
Vallés, P. G., LaPointe, M. S., Wysocki, J. A., & BATLLE, D. C. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.07.004 · Cited by 22
Developmental programming of cardiovascular disorders: Focus on hypertension
MohanKumar, S. M. J., King, A., Shin, A. C., Sirivelu, M. P., MohanKumar, P. S., & Fink, G. D. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9047-z · Cited by 22
Protein tyrosine kinase 2β as a candidate gene for hypertension
Kamide, K., Kokubo, Y., Fukuhara, S., Hanada, H., Yang, J., Kada, A., Nagura, J., Takiuchi, S., Horio, T., Kawano, Y., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282ef640e · Cited by 21
Angiotensin II and renal medullary blood flow in Lyon rats
Sarkis, A., Liu, K. L., Lo, M., & Benzoni, D. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00248.2002 · Cited by 21
Vanderriele, P., Caroccia, B., Seccia, T. M., Piazza, M., Lenzini, L., Torresan, F., Iacobone, M., Unger, T., & Rossi, G. P. (2018) · Clinical Science · doi:10.1042/cs20171593 · Cited by 20
Peddapalli, A., Gehani, M., Kalle, A. M., Peddapalli, S. R., Peter, A. E., & Sharad, S. (2021) · Viruses · doi:10.3390/v13030378 · Cited by 19
Gelinas, L., Falkenham, A., Oxner, A., Sopel, M. J., & Légaré, J. (2011) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310391332 · Cited by 18
da Silva, M. G., Barbosa, S. L. F., Silva, D. S., Bezerra, I. B. M., Bezerra, É. A., Coêlho, A. G., Morais, I. C. P. D. S., Júnior, L. M. R., do Carmo, I. S., Neto, J. D. S. L., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8499625 · Cited by 17
Aimo, A., Vergaro, G., Passino, C., & Clerico, A. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1942782 · Cited by 17
Novel 18F-Labeled PET Imaging Agent FV45 Targeting the Renin–Angiotensin System
Chen, X., Hirano, M., Werner, R. A., Decker, M. W., & Higuchi, T. (2018) · ACS Omega · doi:10.1021/acsomega.8b01885 · Cited by 17
How Can the Differences Among AT1-Receptor Antagonists Be Explained?
Morsing, P., & Vauquelin, G. (2001) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:35:1:89 · Cited by 17
Kutumova, E., Kiselev, I., Sharipov, R., Lifshits, G., & Kolpakov, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.746300 · Cited by 16
Tutunea-Fatan, E., Abd‐Elrahman, K. S., Thibodeau, J.-F., Holterman, C. E., Holleran, B. J., Leduc, R., Kennedy, C., Gros, R., & Ferguson, S. S. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-29876-8 · Cited by 16
Tsuchitani, T., Tomaru, A., Aoki, Y., Ishiguro, N., Tsuda, Y., & Sugiyama, Y. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13154 · Cited by 15
Sharifi, F., Reisi, P., & Malek, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116775 · Cited by 15
The role of angiotensin II and relaxin in vascular adaptation to pregnancy
Doan, T. N. A., Bianco‐Miotto, T., Parry, L. J., & Winter, M. A. (2022) · Reproduction · doi:10.1530/rep-21-0428 · Cited by 15
Angiotensin II Type 1 and 2 Receptors in Conduit Arteries of Normal Developing Microswine
Bagby, S. P., LeBard, L. S., Luo, Z., Speth, R. C., Ogden, B. E., & Corless, C. L. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022382.61262.3e · Cited by 15
Moraes, D. S., Lelis, D. D. F., Andrade, J. M. O., Meyer, L., Guimarães, A. L. S., de Paula, A. M. B., Farias, L. C., & Santos, S. H. S. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106501 · Cited by 15
Physiology and Regulation of the Renin–Angiotensin–Aldosterone System
Carey, R. M., & Padia, S. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00001-5 · Cited by 14
Zheng, W., Ji, H., Szabó, Z. R., Brown, P. R., Yoo, S., & Sandberg, K. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051881.x · Cited by 14
Comparative analysis of amphibian and mammalian angiotensin receptors
Sandberg, K. L., & Ji, H. L. (2001) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(00)00297-x · Cited by 14
Rybczyńska, A., Jurska-Jasko, A., Boblewski, K., Lehmann, A., & Orlewska, C. (2010) · PubMed · Cited by 14
Casare, F. A. M., Milan, D. E., & Fernández, R. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0256 · Cited by 13
Mathematical modeling of antihypertensive therapy
Kutumova, E. O., Kiselev, I. N., Sharipov, R., Израйлевна, Л. Г., & Kolpakov, F. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1070115 · Cited by 13
Cardiovascular role of angiotensin type1A receptors in the nucleus of the solitary tract of mice
Abegaz, B., Davern, P. J., Jackson, K. L., Nguyen‐Huu, T., Bassi, J. K., Connelly, A. A., Choong, Y., Allen, A. M., & Head, G. A. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt183 · Cited by 13
Self-citationReinhold, S. W., Krüger, B., Barner, C., Zoicas, F., Kammerl, M., Hoffmann, U., Bergler, T., Banas, B., & Krämer, B. K. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320311432184 · Cited by 13
Angiotensin II (de)sensitization: Fluid intake studies with implications for cardiovascular control
Daniels, D. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.01.020 · Cited by 13
Kalynovska, N., Diallo, M., & Paleček, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.008 · Cited by 13
Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices
Sobowale, C., Hori, Y., & Ajijola, O. A. (2020) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2020.110705 · Cited by 13
(Pro)renin Receptor and Blood Pressure Regulation: A Focus on the Central Nervous System
Earley, Y. F., & Souza, L. A. C. (2022) · Current Hypertension Reviews · doi:10.2174/1570162x20666220127105655 · Cited by 13
Pathophysiology of Primary Hypertension
Carey, R. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00020-6 · Cited by 13
Newton, T. F., Garza, R. D. L., & Grasing, K. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.11.011 · Cited by 12
El-Haddad, M. A., Ismail, Y., Gayle, D. A., & Ross, M. G. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00479.2003 · Cited by 12
Pharmacological Potential of Exercise and RAS Vasoactive Peptides for Prevention of Diseases
Petriz, B. A., de Almeida, J. A., Migliolo, L., & Franco, O. L. (2013) · Current Protein and Peptide Science · doi:10.2174/13892037113149990063 · Cited by 12
Becker, B., Wang, H., & Zucker, I. H. (2017) · Autonomic Neuroscience · doi:10.1016/j.autneu.2017.05.009 · Cited by 12
Synthesis of the Novel AT1 Receptor Tracer [18F]Fluoropyridine–Candesartan via Click Chemistry
Diaz, A. M. A., Drumeva, G. O., Petrenyov, D. R., Carrier, J., & DaSilva, J. N. (2020) · ACS Omega · doi:10.1021/acsomega.0c02310 · Cited by 12
Füchtbauer, L. M., Toft‐Hansen, H., Khorooshi, R., & Owens, T. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9371-8 · Cited by 12
Samuel, C. S., Li, Y., Wang, Y., & Widdop, R. E. (2022) · British Journal of Pharmacology · doi:10.1111/bph.16019 · Cited by 11
Ivanova, N. M., Atanasova, D., Pechlivanova, D., Mitreva, R., Lazarov, N., Stoynev, A. G., & Tchekalarova, J. D. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.06.036 · Cited by 11
Iovino, M., Messana, T., Pergola, G. D., Iovino, E., Guastamacchia, E., Licchelli, B., Vanacore, A., Giagulli, V. A., & Triggiani, V. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190617160934 · Cited by 11
Bhullar, S. K., & Dhalla, N. S. (2023) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2023-0226 · Cited by 11
Organ Selective Regulation of Sympathetic Outflow by the Brain Angiotensin System
Ramchandra, R., Yao, S. T., & May, C. N. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0355-2 · Cited by 11
Ismail, B., deKemp, R. A., Hadizad, T., Mackasey, K., Beanlands, R. S., & DaSilva, J. N. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0209-4 · Cited by 11
Guilherme, R., Patrier, S., Gübler, M.-C., Lemercier, D., Guimiot, F., & Dommergues, M. (2009) · Placenta · doi:10.1016/j.placenta.2009.06.001 · Cited by 10
Sniffer cells for the detection of neural Angiotensin II in vitro
Farmer, G. E., Amune, A., Bachelor, M., Duong, P., Yuan, J. P., & Cunningham, J. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-45262-4 · Cited by 10
Nasimi, A., & Kafami, M. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.01.003 · Cited by 10
Chen, D., Hazelwood, L., Walker, L., Oldfield, B. J., McKinley, M. J., & Allen, A. M. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00462.2009 · Cited by 10
Self-citationAngiotensin receptors in Dupuytren’s disease: a target for pharmacological treatment?
Stephen, C., Touil, L. L., Vaiude, P., Singh, J., & McKirdy, S. W. (2017) · Journal of Plastic Surgery and Hand Surgery · doi:10.1080/2000656x.2017.1319846 · Cited by 10
Ismail, B., Hadizad, T., Antoun, R., Lortie, M., deKemp, R. A., Beanlands, R. S., & DaSilva, J. N. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.06.012 · Cited by 9
Davis, G. K., Intapad, S., Newsome, A. D., Coats, L. E., Bamrick, D. R., Ojeda, N. B., & Alexander, B. T. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13257 · Cited by 9
Maejima, S., Konno, N., Matsuda, K., & Uchiyama, M. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.05.007 · Cited by 9
Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity
Santra, D., Banerjee, A., De, S. K., Thatoi, H., & Maiti, S. (2023) · Comparative Clinical Pathology · doi:10.1007/s00580-023-03434-9 · Cited by 9
Differential regulation of H+-ATPases in MDCK-C11 cells by aldosterone and vasopressin
dos Santos, P. M. C., de Freitas, F. P. P., Mendes, J., Tararthuch, A. L., & Fernández, R. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-057 · Cited by 9
Pathophysiology of Primary Hypertension
Carey, R. M. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020418 · Cited by 9
Kafami, M., & Nasimi, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.050 · Cited by 8
Non‐HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation
Chan, A. P., Guerra, M. R., Rossetti, M. M., Hickey, M. J., Venick, R. S., Marcus, E. A., McDiarmid, S. V., Farmer, D. G., Reed, E. F., & Wozniak, L. J. (2021) · Pediatric Transplantation · doi:10.1111/petr.13987 · Cited by 8
Physiology and Regulation of the Renin–Angiotensin–Aldosterone System
Carey, R. M., & Padia, S. H. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00012-0 · Cited by 8
Ischemic heart disease down-regulates angiotensin type 1 receptor mRNA in human coronary arteries
Wackenfors, A., Emilson, M., Ingemansson, R., Edvinsson, L. I., & Malmsjö, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.039 · Cited by 8
Neurovascular Control and Cardiac Structure in Amateur Runners with Hypertension
Perlingeiro, P. D. S., Azevedo, L. F., Gomes-Santos, I. L., Bortolotto, L. A., Rondon, M. U. P. B., Negrão, C. E., & de Matos, L. D. N. J. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000751 · Cited by 7
Jacques, D., Abdel-Malak, N. A.-K., Abdallah, N. A., Al-Khoury, J., & Bkaily, G. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0280 · Cited by 7
Selective activation of protein kinase C isoforms by angiotensin II in neuroblastoma X glioma cells
Greenland, K. J., & Mukhopadhyay, A. K. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.028 · Cited by 7
Cardiac-Specific Overexpression of Angiotensin II Type 1 Receptor in Transgenic Rats
Hoffmann, S. (2005) · Humana Press eBooks · doi:10.1385/1-59259-879-x:389 · Cited by 7
Rölz, W., Xin, C., Ren, S., Pfeilschifter, J. M., & Huwiler, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01545-5 · Cited by 7
Interaction of Bisphenol A with G Protein: Coupled Receptors - New Paradigms in Breast Cancer
Molina, L., Figueroa, C. D., & Ehrenfeld, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101204 · Cited by 6
Santollo, J., Collett, J. A., & Edwards, A. A. (2021) · Physiological Reports · doi:10.14814/phy2.14948 · Cited by 6
Potassium Derangements: A Pathophysiological Review, Diagnostic Approach, and Clinical Management
Sharif, S., & Tang, J. T. (2022) · Physiology · doi:10.5772/intechopen.103016 · Cited by 6
Chatzipieris, F. P., Petsas, E., Lambrinidis, G., Matsoukas, J., & Mavromoustakos, T. (2025) · Biomolecules · doi:10.3390/biom16010020 · Cited by 5
Endocytosis and signaling of angiotensin II type 1 receptor
Mani, I. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.08.005 · Cited by 5
Blood-Pressure-Lowering and Endothelium-Dependent Vasorelaxant Effects of Nutgall Tree in Rats
Shin, S., Park, J., Choi, H.-Y., Bu, Y., & Lee, K. (2024) · Foods · doi:10.3390/foods13071041 · Cited by 5
Stress, Angiotensin, and Cognate Receptors
Aguilera, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00024-3 · Cited by 5
Singh, S., Moodley, J., Khaliq, O. P., & Naicker, T. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01158-1 · Cited by 5
Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors
Hosseini-Dastgerdi, H., Kharazmi, F., Pourshanazari, A., & Nematbakhsh, M. (2022) · International Journal of Nephrology · doi:10.1155/2022/8731357 · Cited by 5
Cardiac and Vascular Renin-Angiotensin Systems
Kumar, R., Baker, K. M., & Pan, J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-987-5_2 · Cited by 5
Nuevos farmacos en insuficiencia cardíaca
Lopera, G., Castellanos, A., & de Marchena, E. (2001) · Revista Española de Cardiología · doi:10.1016/s0300-8932(01)76365-8 · Cited by 5
Okarvi, S. M. (2023) · Pharmaceuticals · doi:10.3390/ph16111550 · Cited by 4
Diaz, A. M. A., Drumeva, G. O., Laporte, P., Martinez, L. M. A., Petrenyov, D. R., Carrier, J., & DaSilva, J. N. (2021) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2021.03.003 · Cited by 4
miRNA regulation of G protein-coupled receptor mediated angiogenic pathways in cancer
Mandal, S., Chakrabarty, D., Bhattacharya, A., Paul, J., Haldar, S., & Pal, K. (2021) · The Nucleus · doi:10.1007/s13237-021-00365-0 · Cited by 4
The contribution of angiotensin peptides to cardiovascular neuroregulation in health and disease
Szczepanska‐Sadowska, E. K., Żera, T., Kowara, M., & Cudnoch‐Jędrzejewska, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99618-1.00009-x · Cited by 4
Gralinski, M., Neves, L. A. A., & Tiniakova, O. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_141 · Cited by 4
Intricacies of brain angiotensin II signalling pathways
Denton, K. M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000198046.77622.4e · Cited by 4
Multani, M. M., Krombach, R. S., Goldberg, A. T., King, M. K., Hendrick, J. W., Sample, J. A., Baicu, S., Joffs, C., deGasparo, M., & Spinale, F. G. (2001) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840100600406 · Cited by 4
The Endocrine–Paracrine Control of the Cardiovascular System
Tota, B., & Cerra, M. C. (2009) · Springer eBooks · doi:10.1007/978-3-540-93985-6_14 · Cited by 4
Uhlenius, N., Vuolteenaho, O. J., & Tikkanen, I. T. (2001) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2001.037 · Cited by 4
Role of local angiotensin II signaling in bladder function
Anderson, H. A., Robilotto, G. L., & Mickle, A. D. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00204.2024 · Cited by 3
Elkabily, A. G., & Sebaiy, M. M. (2020) · Trends in Medicine · doi:10.15761/tim.1000233 · Cited by 3
Daniels, D. (2013) · Frontiers in neuroscience · doi:10.1201/b15544-6 · Cited by 3
Metadata
- Authors
- ALLEN, A.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- ALLEN, A
- ORCID
- ALLEN, A
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01
- Volume
- 13
- Issue
- 1
- Pages
- S31-S38
- ISSN
- 0895-7061 (ISSN-L)
- OpenAlex
- W2037211353
- Cited by
- 278
- References
- 74
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 10 · 2022: 14 · 2021: 21 · 2020: 12 · 2019: 11 · 2018: 11 · 2017: 11 · 2016: 15 · 2015: 10 · 2014: 3 · 2013: 13 · 2012: 13
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- angiotensin II type 1 receptor, angiotensin II type 2 receptor, receptor distribution, cardiac conduction system, vagal ganglia, circumventricular organs, neuromodulation, adrenal cortex, renal blood flow, fluid reabsorption, cell proliferation inhibition, receptor binding
- MeSH terms
- Animals, Humans, Kidney, Myocardium, Receptors, Angiotensin, Renin-Angiotensin System, Receptor, Angiotensin, Type 2, Receptor, Angiotensin, Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.